Page last updated: 2024-08-23

bromocriptine and Island Cell Tumor

bromocriptine has been researched along with Island Cell Tumor in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burshell, AL; Pathak, RD; Tran, TH1
De Herder, WW; Hofland, LJ; Kros, MJ; Lamberts, SW; Uitterlinden, P; Van Koetsveld, PM; Van Uffelen, C; Visser-Wisselaar, HA; Waaijers, M; Zuyderwijk, J1
Child, DF; Ganguli, PC; Laing, I1

Other Studies

3 other study(ies) available for bromocriptine and Island Cell Tumor

ArticleYear
A case of dopamine agonists inhibiting pancreatic polypeptide secretion from an islet cell tumor.
    The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:2

    Topics: Adenoma, Islet Cell; Bromocriptine; Chromogranin A; Chromogranins; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Humans; Liver Neoplasms; Neoplasms, Multiple Primary; Pancreatic Neoplasms; Pancreatic Polypeptide; Prolactinoma

2004
Dissociation between the effects of somatostatin (SS) and octapeptide SS-analogs on hormone release in a small subgroup of pituitary- and islet cell tumors.
    The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:9

    Topics: Adenoma; Adenoma, Islet Cell; Aminoquinolines; Bromocriptine; Dopamine Agonists; Endocrine Gland Neoplasms; Hormone Antagonists; Hormones; Humans; Insulinoma; Pancreatic Neoplasms; Pituitary Neoplasms; Prolactinoma; Receptors, Somatostatin; Somatostatin; Tumor Cells, Cultured

1997
Failure of oral bromocriptine to affect hypergastrinemia in two patients with the Zollinger-Ellison syndrome.
    Journal of endocrinological investigation, 1978, Volume: 1, Issue:4

    Topics: Adenoma; Adenoma, Islet Cell; Adult; Bromocriptine; Gastrins; Growth Hormone; Humans; Male; Middle Aged; Pancreatic Neoplasms; Peptic Ulcer; Zollinger-Ellison Syndrome

1978